Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Metabolic syndrome, leaky guts, and infection: Metabolic syndrome often accompanies obesity and hyperglycemia and is associated with a breakdown in the integrity of the intestinal barrier and increased risk of systemic infection. Thaiss et al. found that mice with systemic infection of a Salmonella analog, Citrobacter rodentium , also exhibited hyperglycemia. Deletion of the glucose transporter GLUT2 altered sensitivity to chemically induced epithelial permeability and protected mice from pathogen invasion. The authors also found a correlation in humans between glycated hemoglobin (an indicator of hyperglycemia) and serum levels of pathogen recognition receptor ligands. Science , this issue p. 1376
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thaiss et al. clearly showed that hyperglycemia drives intestinal permeability by the glucose transporter GLUT2-dependent transcriptional reprogramming of intestinal epithelial cells, resulting in changes in tight and adherence junction integrity, and a systemic influx of microbial products into portal blood [274].”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [274]
Citations
Cites
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H., & Glass, C. K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.004 · Cited by 13,382
TopHat: discovering splice junctions with RNA-Seq
Trapnell, C., Pachter, L., & Salzberg, S. L. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp120 · Cited by 11,617
DAVID: Database for Annotation, Visualization, and Integrated Discovery
Dennis, G., Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C., & Lempicki, R. A. (2003) · Genome Biology · doi:10.1186/gb-2003-4-5-p3 · Cited by 9,327
Origin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618
Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R. (2008) · Diabetes · doi:10.2337/db07-1403 · Cited by 4,819
Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622
Inflammation, metaflammation and immunometabolic disorders
Hotamisligil, G. S. (2017) · Nature · doi:10.1038/nature21363 · Cited by 2,570
Massively parallel single-cell RNA-seq for marker-free decomposition of tissues into cell types
Jaitin, D. A., Kenigsberg, E., Keren-Shaul, H., Elefant, N., Paul, F., Zaretsky, I., Mildner, A., Cohen, N., Jung, S., Tanay, A., et al. (2014) · Science · doi:10.1126/science.1247651 · Cited by 1,795
Van der Sluis, M., De Koning, B. A. E., De Bruijn, A. C. J. M., Velcich, A., Meijerink, J. P. P., Van Goudoever, J. B., Büller, H. A., Dekker, J., Van Seuningen, I., Renes, I. B., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.04.020 · Cited by 1,684
Cited by
Items 201–300 of 965
Li, X., Huang, G., Zhang, Y., Ren, Y., Zhang, R., Zhu, W., & Yu, K. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106865 · Cited by 56
Bio-inspired intestinal scavenger from microfluidic electrospray for detoxifying lipopolysaccharide
Zhao, C., Chen, G., Wang, H., Zhao, Y., & Chai, R. (2020) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.11.017 · Cited by 57
“In the pathogenesis of MetS, intestinal barrier function plays an important role in prevention and treatment [41].”
BackgroundHulme, K. D., Noye, E. C., Short, K. R., & Labzin, L. I. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.770066 · Cited by 56
Forlano, R., Mullish, B. H., Roberts, L. A., Thursz, M. R., & Manousou, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020662 · Cited by 54
“Finally, inadequate glycaemic control has been associated with increased translocation of microbial products in the systemic circulation [53].”
BackgroundInfluentialGut-liver axis: Pathophysiological concepts and medical perspective in chronic liver diseases
Rodrigues, S. G., der Merwe, V., Krag, A. A., & Wiest, R. (2024) · Seminars in Immunology · doi:10.1016/j.smim.2023.101859 · Cited by 57
Age-Onset Phosphorylation of a Minor Actin Variant Promotes Intestinal Barrier Dysfunction
Egge, N., Arneaud, S. L. B., Wales, P., Mihelakis, M., McClendon, J., Fonseca, R. S., Savelle, C., Gonzalez, I. J., Ghorashi, A. C., Yadavalli, S., et al. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.11.001 · Cited by 53
“, 2018), and hyperglycemia-induced systemic infection (Thaiss et al., 2018).”
Hage, R. E., Hernandez‐Sanabria, E., Calatayud, M., & de Wiele, T. V. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00523.2019 · Cited by 54
Wei, Y., Gao, J., Kou, Y., Liu, M., Meng, L., Zheng, X., Xu, S., Ming, L., Sun, H., Liu, Z., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201902900rr · Cited by 56
Systemic Immunoregulatory Consequences of Gut Commensal Translocation
McPherson, A. C., Pandey, S., Bender, M. J., & Meisel, M. (2021) · Trends in Immunology · doi:10.1016/j.it.2020.12.005 · Cited by 52
Joo, J. E., Clendenning, M., Wong, E. M., Rosty, C., Mahmood, K., Georgeson, P., Winship, I., Preston, S., Win, A. K., Dugué, P., et al. (2021) · Cancers · doi:10.3390/cancers13112589 · Cited by 53
“Like other forms of diabetes, MODY is linked to obesity and hyperglycaemia [53], which are known causative factors for intestinal inflammation and are also linked to gut microbiome dysbiosis [54].”
BackgroundGut microbiota and host genetics modulate the effect of diverse diet patterns on metabolic health
Huda, M. N., Salvador, A. C., Barrington, W. T., Gacasan, C. A., D’Souza, E. M., Ramirez, L. D., Threadgill, D. W., & Bennett, B. J. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.896348 · Cited by 55
“Conversely, risk factors of MetS also affect the gut microbiota and further worsen metabolic health (30).”
BackgroundIncreased Colonic Permeability and Lifestyles as Contributing Factors to Obesity and Liver Steatosis
Palo, D. M. D., Garruti, G., Ciaula, A. D., Molina‐Molina, E., Shanmugam, H., Angelis, M. D., & Portincasa, P. (2020) · Nutrients · doi:10.3390/nu12020564 · Cited by 52
“In principle, alterations of the gastrointestinal permeability could also increase the risk of systemic diseases, such as obesity [49] and diabetes [50,51].”
BackgroundZhang, X., Monnoye, M., Mariadassou, M., Béguet-Crespel, F., Lapaque, N., Heberden, C., & Douard, V. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.742584 · Cited by 54
“Since fructose is also associated with increase in glycemia (29, 35), which is associated with increase in intestinal permeabilibity in a GLUT2-dependent manner (28), the direct role of luminal fructose on the gut barrier function must be questioned.”
BackgroundInfluentialUric acid drives intestinal barrier dysfunction through TSPO-mediated NLRP3 inflammasome activation
Lv, Q., Xu, D., Ma, J., Wang, Y., Yang, X., Zhao, P., Ma, L., Li, Z., Yang, W. Q., Liu, X., et al. (2020) · Inflammation Research · doi:10.1007/s00011-020-01409-y · Cited by 49
Lv, Q., Li, Z., Sui, A., Yang, X., Han, Y., & Yao, R. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.977187 · Cited by 59
“In diabetes, hyperglycemia-mediated barrier disruption enhances the dissemination of enteric infection and increases susceptibility to pathogenic microbes, which may be another key factor for the progression of CVD (Thaiss et al., 2018).”
BackgroundThe role of lipopolysaccharides in diabetic retinopathy
Qin, X., & Zou, H. (2022) · BMC Ophthalmology · doi:10.1186/s12886-022-02296-z · Cited by 53
“Abbreviations AGE: Advanced glycation end product; APC: Antigen-presenting cell; BRB: Blood-retina barrier; CXCL: C-X-C motif ligand; DM: Diabetes mellitus; DME: Diabetic macular oedema; DR: Diabetic retinopathy; ER: Endoplasmic reticulum; GFAP: Glial fibrillary acidic protein; ICAM: Intercellular cell adhesion molecu…”
BackgroundInfluentialAdeshirlarijaney, A., Zou, J., Tran, H. Q., Chassaing, B., & Gewirtz, A. T. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00245.2019 · Cited by 47
Gueddouri, D., Caüzac, M., Fauveau, V., Benhamed, F., Charifi, W., Beaudoin, L., Rouland, M., Sicherre, F., Lehuen, A., Postic, C., et al. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101438 · Cited by 49
“While a higher risk of infection by enteropathogens was reported in db/db or high fat-diet fed obese and diabetic mice, in STZ-treated diabetic mice [17] as well as in diabetic patients [71], rescuing the compromised production of IL23 in obese mice after Citrobacter rodentium infection was sufficient to restore the m…”
BackgroundInfluentialYi, X., Ren, M., Yang, J., Cai, C., Cheng, W., Zhou, X., Lu, D., & Ji, F. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1003755 · Cited by 48
“Mice fed with a high-fat diet (HFD) are protected from increased intestinal permeability in the absence of the gut microbiota (Thaiss et al., 2018).”
BackgroundGut microbiome-mediated mechanisms in aging-related diseases: are probiotics ready for prime time?
Ren, J., Li, H., Zeng, G., Pang, B., Wang, Q., & Wei, J.-P. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1178596 · Cited by 54
“Recently, a study published in Science has found that in T2DM and obese mouse models, hyperglycemia led to intestinal barrier dysfunction through the recombination of glucose transporter 2dependent intestinal epithelial cells, altered tight junctions, and adhesion protein integrity (Thaiss et al., 2018).”
BackgroundDiabetes Mellitus and Infectious Diseases: Current Evidence and Clinical Implications
Kim, T., & Choi, S. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0508 · Cited by 60
“Hyperglycemia disrupts skin and mucosal epithelial integrity, increasing susceptibility to diabetic foot ulcers and enteric infections [48].”
Zang, J., Xiao, L., Shi, Y., Kou, Y., Ma, K., Zhang, C., Rui, X., Lin, T., & Li, W. (2026) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.70383 · Cited by 48
Intestinal plasticity in response to nutrition and gastrointestinal surgery
Gall, M. L., Thenet, S., Aguanno, D., Jarry, A., Genser, L., Ribeiro‐Parenti, L., Joly, F., Ledoux, S., Bado, A., & Beyec, J. L. (2018) · Nutrition Reviews · doi:10.1093/nutrit/nuy064 · Cited by 48
Szunerits, S., Melinte, S., Barras, A., Pagneux, Q., Voronova, A., Abderrahmani, A., & Boukherroub, R. (2020) · Chemical Society Reviews · doi:10.1039/c9cs00886a · Cited by 49
Rouland, M., Beaudoin, L., Rouxel, O., Bertrand, L., Cagninacci, L., Saffarian, A., Pédron, T., Gueddouri, D., Guilmeau, S., Burnol, A., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-323664 · Cited by 47
Enteric neuropathy in diabetes: Implications for gastrointestinal function
Abdalla, M. M. I. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i22.2852 · Cited by 45
Michi, A. N., Yipp, B. G., Dufour, A., Lopes, F., & Proud, D. (2021) · Nature Communications · doi:10.1038/s41467-021-23925-z · Cited by 46
Immune Dysregulation in Obesity
Jiang, Z., Tabuchi, C., Gayer, S. G., & Bapat, S. P. (2025) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-051222-015350 · Cited by 52
Zhang, Z., Xie, Y., Yi, Q., Liu, J., Yang, L., Wang, R., Cai, J., Li, X., Feng, X., Yao, S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62107-z · Cited by 52
“Colonic epithelial cells were isolated according to standard procedures 7 .”
Orientationally engineered 2D/3D perovskite for high efficiency solar cells
Abbas, M. S., Hussain, S., Zhang, J., Wang, B., Yang, C., Wang, Z., Wei, Z., & Ahmad, R. M. (2019) · Sustainable Energy & Fuels · doi:10.1039/c9se00817a · Cited by 45
Microbial and Host Factors That Affect Bacterial Invasion of the Gingiva
Ji, S., & Choi, Y. (2020) · Journal of Dental Research · doi:10.1177/0022034520922134 · Cited by 47
“Importantly, inhibition of glucose metabolism or glucose transport to the intestinal epithelium restored the barrier function and protected hosts from enteric infection (Thaiss et al. 2018).”
BackgroundLipid droplets, autophagy, and ageing: A cell-specific tale
Maestri, A., Garagnani, P., Pedrelli, M., Hagberg, C. E., Parini, P., & Ehrenborg, E. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102194 · Cited by 48
“…exogenous stimuli in an aged system, such as increased levels of circulating TLR ligands, namely LPS, caused by a decreased gut barrier functionality or increased advanced glycation end products (AGEs), which can activate macrophages via TLR4 and RAGE (Ohtsu et al., 2017; Thaiss et al., 2018).”
Yang-Jensen, S. K., Nägele, N. S., & Jensen, B. A. H. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00704.2025 · Cited by 47
Tang, J., Wang, X., Chen, S., Chang, T., Gu, Y., Zhang, F., Hou, J., Luo, Y., Li, M., Huang, J., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114648 · Cited by 47
Dietary and metabolic effects on intestinal stem cells in health and disease
Shay, J. E. S., & Yilmaz, Ö. H. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00980-7 · Cited by 63
Pereira, M. T., Malik, M., Nostro, J. A., Mahler, G. J., & Musselman, L. P. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.034520 · Cited by 47
“Hyperglycemic, insulin-resistant mice exhibit increased intestinal permeability and infection susceptibility, both of which are GLUT2 dependent (Thaiss et al., 2018).”
Shelton, C. D., & Byndloss, M. X. (2020) · Infection and Immunity · doi:10.1128/iai.00939-19 · Cited by 46
“Systemic hyperglycemia contributes to obesity-associated impairment in intestinal epithelium barrier functions (126).”
BackgroundSu, H., Mo, J., Ni, J., Ke, H., Bao, T., Xie, J., Xu, Y., Xie, L., & Chen, W. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/6538930 · Cited by 55
Arnone, D., Vallier, M., Hergalant, S., Chabot, C., Ndiaye, N. C., Moulin, D., Aignatoaei, A.-M., Alberto, J., Louis, H., Boulard, O., et al. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.758518 · Cited by 45
“A landmark study showed that experimental type 2 diabetes drives intestinal barrier dysfunction by transcriptional reprogramming of intestinal epithelial cells and alteration of tight and adherens junctions integrity (11).”
BackgroundMethodInfluentialSanidad, K. Z., Wang, G., Panigrahy, A., & Zhang, G. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.156776 · Cited by 45
Lactobacillus paracasei CNCM I-5220-derived postbiotic protects from the leaky-gut
Algieri, F., Tanasković, N., Rincón, C. L. C., Notario, E., Braga, D., Pesole, G., Rusconi, R., Penna, G., & Rescigno, M. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1157164 · Cited by 47
“Junction tortuosity was calculated as a ratio between junction length and Euclidean distance between its ends, as previously published (Thaiss et al., 2018).”
MethodTang, Z., Yu, S., & Pan, Y. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04455-2 · Cited by 50
Cho, J. H., Chae, C. W., Lim, J. R., Jung, Y. H., Han, S. J., Yoon, J. H., Park, J. Y., & Han, H. J. (2024) · Autophagy · doi:10.1080/15548627.2024.2323785 · Cited by 48
“…activity through alterations in the gut metabolome, and a disruption of the integrity of the gut barrier in the hyperglycemic environment [45,46], these discrepancies at the phylum level might be due to interspecies differences; thus, our data provided basic information on the change in the…”
ResultShen, L., Li, A., Xu, H., Shi, J., You, D., Yu, X., Xu, W., Sun, J., & Wang, F. (2019) · BMC Endocrine Disorders · doi:10.1186/s12902-019-0354-7 · Cited by 43
“T2DM patients also tend to be associated with a series of chronic complications, such as nerve, blood vessel and gastrointestinal tract defects including intestinal mucosal barrier damage, seriously affecting the life quality [4, 5].”
BackgroundSikora, M., Chrabąszcz, M., Waśkiel‐Burnat, A., Rakowska, A., Olszewska, M., & Rudnicka, L. (2019) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.15700 · Cited by 46
Anesi, J. A., Lautenbach, E., Tamma, P. D., Thom, K. A., Blumberg, E. A., Alby, K., Bilker, W. B., Werzen, A., Tolomeo, P., Omorogbe, J., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa190 · Cited by 42
Type I IFNs and CD8 T cells increase intestinal barrier permeability after chronic viral infection
Labarta-Bajo, L., Nilsen, S. P., Humphrey, G., Schwartz, T., Sanders, K., Swafford, A. D.-E., Knight, R. D., Turner, J. R., & Zúñiga, E. I. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20192276 · Cited by 47
Liu, M., Huang, B., Wang, L., Lu, Q., & Liu, R. (2022) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.11945 · Cited by 43
Sun, S., Yang, Y., Xiong, R., Ni, Y., Ma, X., Hou, M., Chen, L., Xu, Z., Chen, L., & Ji, M. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121141 · Cited by 44
The gut microbiota‐astrocyte axis: Implications for type 2 diabetic cognitive dysfunction
Li, Z.-H., Jiang, Y., Long, C., Peng, Q., & Yue, R. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14077 · Cited by 43
Zhang, L., Xue, X., Zhai, R., Yang, X., Li, H., Zhao, L., & Zhang, C. (2019) · mSystems · doi:10.1128/msystems.00348-19 · Cited by 41
“A previous study identified that hyperglycemia correlated with a loss of intestinal barrier permeability (25).”
BackgroundMorresi, C., Cianfruglia, L., Sartini, D., Cecati, M., Fumarola, S., Emanuelli, M., Armeni, T., Ferretti, G., & Bacchetti, T. (2019) · Cells · doi:10.3390/cells8121616 · Cited by 41
“Moreover, alterations of intestinal glucose transport and epithelial integrity leading to an abnormal influx of immune stimulatory microbial products and a propensity for systemic spread of entry of pathogens has been demonstrated in animal models [16,67,68].”
BackgroundMethodTveter, K. M., Villa-Rodríguez, J. A., Cabales, A., Zhang, L., Bawagan, F. G., Duran, R. M., & Roopchand, D. E. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001386 · Cited by 42
“17 Compared with LFD-fed controls, db/db mice fed LFD containing PAC-rich GPs (LFD-GP) for 4 weeks showed significantly improved oral glucose tolerance (figure 1A).”
Effect of altered human exposome on the skin and mucosal epithelial barrier integrity
Pat, Y., Öğülür, İ., Yazıcı, D., Mitamura, Y., Cevhertas, L., Küçükkase, O. C., Mesisser, S. S., Akdiş, M., Nadeau, K. C., & Akdiş, C. A. (2022) · Tissue Barriers · doi:10.1080/21688370.2022.2133877 · Cited by 45
“114 Obesity is associated with higher gas-troduodenal permeability (but not small intestine and colonic) with a pro-inflammatory systemic and intestinal profile.”
BackgroundInnovations in Geroscience to enhance mobility in older adults
Anton, S. D., Cruz‐Almeida, Y., Singh, A., Alpert, J. M., Bensadon, B. A., Cabrera, M., Clark, D. J., Ebner, N. C., Esser, K. A., Fillingim, R. B., et al. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.111123 · Cited by 46
Contribution of the commensal microbiota to atherosclerosis and arterial thrombosis
Kiouptsi, K., & Reinhardt, C. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14483 · Cited by 42
“Nutrition and related changes in the gut microbiota influence the intestinal barrier function, increasing gut permeability (Cani et al., 2008; Thaiss et al., 2018).”
BackgroundCheru, L., Park, J., Saylor, C. F., Burdo, T. H., Fitch, K. V., Looby, S. E. D., Weiner, J., Robinson, J. A., Hubbard, J. L., Torriani, M., et al. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy288 · Cited by 39
“Indeed, recent key scientific studies have shown that local high-glucose concentrations can be a driver of intestinal epithelial damage [33] and that saturated fat [34] can induce damage to the intestinal mucosa.”
BackgroundLu, Q., Huang, T., Zhou, J., Zeng, Y., Wu, C., Liu, M., Li, H., Zhang, Y., & Yao, S. (2020) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2020.118893 · Cited by 40
Diener, C., Reyes‐Escogido, M. D. L., Jiménez-Ceja, L. M., Matus, M. G., Navarro, C. M. G., Chu, N. D., Zhong, V., Tejero, M. E., Alm, E. J., Reséndis-Antonio, O., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.602326 · Cited by 45
“Hyperglycemia itself has been shown to increase the risk for enteric infection by driving intestinal barrier permeability which is consistent with the tight association we observe between Escherichia abundance and blood glucose levels (48).”
BackgroundWestern-style diet impedes colonization and clearance of Citrobacter rodentium
An, J., Zhao, X., Wang, Y., Noriega, J., Gewirtz, A. T., & Zou, J. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009497 · Cited by 42
“rodentium infection as described previously [27], and associated with delayed but nonetheless eventual complete clearance of the pathogen (S5B Fig).”
BackgroundYang, Y., Zhao, M., He, X., Wu, Q., Li, D., & Zang, W. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.647481 · Cited by 45
“Hyperglycemia-mediated barrier disruption facilitated harmful bacterial antigens and microorganisms from the intestinal lumen to blood, lymph, and extraintestinal tissues (Thaiss et al., 2018; Allam-Ndoul et al., 2020).”
BackgroundPersonalizing Nutrition Strategies: Bridging Research and Public Health
Clemente‐Suárez, V. J., Peris-Ramos, H. C., Redondo-Flórez, L., Beltrán-Velasco, A. I., Martín-Rodríguez, A., David-Fernandez, S., Sepulveda, R. A. Y., & Tornero-Aguilera, J. F. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14030305 · Cited by 51
“The retina is susceptible to damage due to high glucose concentrations, as it is a metabolically active tissue, resulting in limitations in glucose transporters’ function, causing cellular damage and apoptosis through advanced glycation end-product (AGE) accumulation [378].”
BackgroundIntestinal barrier in chronic gut and liver diseases: Pathogenesis and therapeutic targets
Zhang, Y., Liu, Y., Liang, X., Wen, Y., Zhao, J., He, Y., Xie, Q., & Xie, C. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.08.028 · Cited by 45
“…with leptin deficiency ( ob / ob ) and leptin receptor (LepR) deficiency ( db / db ), hyperglycemia disrupts the intestinal barrier by inducing glucose transporter 2 (GLUT2)- dependent transcriptional reprogramming in IECs, which subsequently impairs the integrity of TJ and AJ structures 110 .”
Li, Y., Zhou, J., Qiu, J., Huang, Z., Wang, W., Wu, P., & Feng, A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118460 · Cited by 39
Hyperglycaemia in the Newborn Infant. Physiology Verses Pathology
Beardsall, K. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.641306 · Cited by 42
“Recent data have also shown a causal pathway linking hyperglycaemia to an increased risk of microbial gut translocation in both animal models and adult studies (56).”
BackgroundWang, J., Zhang, Q., Xia, J., & Sun, H. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s346007 · Cited by 39
“Likewise, obesity-associated complications, such as hyperglycemia, can aggravate intestinal barrier integrity by causing transcriptional reprogramming of intestinal epithelial cells and alteration of tight and adherence junction integrity.(10) Human studies also have shown that higher levels of circulating zonulin (ma…”
BackgroundRewiring host–microbe interactions and barrier function during gastrointestinal inflammation
Yang-Jensen, S. K., Pærregaard, S. I., Brandum, E. P., Jørgensen, A. S., Hjortø, G. M., & Jensen, B. A. H. (2022) · Gastroenterology report · doi:10.1093/gastro/goac008 · Cited by 41
“tion that independently drives barrier dysfunction, thereby enhancing colitis susceptibility and risk of enteric infections through transcriptional reprogramming of intestinal epithelial cells and tight-junction integrity [161].”
Ni, Y., Hu, Y., Lou, X., Rong, N., Liu, F., Yang, C., Zheng, A., Yang, S. T., Bao, J., & Fu, Z. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c02729 · Cited by 39
Inflammatory cytokines directly disrupt the bovine intestinal epithelial barrier
Crawford, C. K., Cervantes, V. L., Quilici, M. L., Armién, A. G., Questa, M., Matloob, M. S., Huynh, L., Beltran, A., Karchemskiy, S., Crakes, K. R., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-18771-y · Cited by 40
Neonatal Hyperglycemia—Causes, Treatments, and Cautions
Hay, W. W., & Rozance, P. J. (2018) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2018.04.046 · Cited by 38
Microbes: possible link between modern lifestyle transition and the rise of metabolic syndrome
Moossavi, S., & Bishehsari, F. (2018) · Obesity Reviews · doi:10.1111/obr.12784 · Cited by 39
“Western diet) accelerate mucin degradation, resulting in gut barrier dysfunction (70), and reduced mucus production and secretion has been observed within the context of high fat-induced obesity in rodents (71), which could further aggravate disrupted barrier integrity observed in insulin resistance (55).”
BackgroundHulme, K. D., Yan, L., Marshall, R. J., Bloxham, C. J., Upton, K. R., Hasnain, S. Z., Bielefeldt‐Ohmann, H., Loh, Z., Ronacher, K., Chew, K. Y., et al. (2020) · eLife · doi:10.7554/elife.56907 · Cited by 37
Macho‐González, A., Garcimartín, A., Redondo, N., Cofrades, S., Bastida, S., Nova, E., Benedí, J., Sánchez-Muniz, F. J., Marcos, A., & López‐Oliva, M. E. (2021) · Food Research International · doi:10.1016/j.foodres.2021.110124 · Cited by 39
Deng, Y., Ouyang, X., Sun, J., Shi, X., Li, Y., Chan, Y. K., Yang, W., & Peng, S. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.07.003 · Cited by 48
Zhen, M., Xu, Y. M., Wang, C., & Bai, C. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202409319 · Cited by 37
Zong, X., Cao, X., Wang, H., Xiao, X., Wang, Y., & Lu, Z. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01674 · Cited by 36
“A poorly understood feature of metabolic syndrome is that it is associated with intestinal barrier dysfunction (8, 30).”
BackgroundMutual Interplay of Host Immune System and Gut Microbiota in the Immunopathology of Atherosclerosis
Yeh, C., Chen, Y.-H., Liu, S.-F., Kao, H., Wu, M., Yang, K., & Wu, W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228729 · Cited by 39
What is the leaky gut? Clinical considerations in humans
Camilleri, M. (2021) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000778 · Cited by 37
Xu, H., Zhao, C., Li, Y., Liu, R., Ao, M., Li, F., Yao, Y., Tao, Z., & Yu, L. (2019) · Food & Function · doi:10.1039/c9fo01599j · Cited by 39
Greathouse, K. L., White, J. R., Padgett, R. N., Perrotta, B. G., Jenkins, G. D., Chia, N., & Chen, J. (2019) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2018-000247 · Cited by 35
“Evidence clearly demonstrates an intimate link between inflammation, obesity, and 11 the microbiome (34, 36, 49-56).”
BackgroundLyte, J. M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00796 · Cited by 35
“Relatedly, ob/ob mice, which are obese due to hyperphagia from being leptin-deficient, exhibit increased intestinal bacterial translocation possibly related to dysregulated glucose metabolism (104) compared to conventional mice (105).”
BackgroundBaddi, S., Dang-i, A. Y., Gao, F., Qiu, X., & Feng, C. (2025) · Progress in Materials Science · doi:10.1016/j.pmatsci.2025.101428 · Cited by 38
Outside the liver box: The gut microbiota as pivotal modulator of liver diseases
Wahlstrom, A. M. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.07.004 · Cited by 37
Mediators of Metabolism: An Unconventional Role for NOD1 and NOD2
Zangara, M. T., Johnston, I., Johnson, E. E., & McDonald, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031156 · Cited by 37
Single-Cell Transcriptomic Atlas of Gingival Mucosa in Type 2 Diabetes
Wang, Q., Lin, W., Zhou, X., Lei, K., Xu, R., Zhang, X., Xiong, Q., Sheng, R., Song, W., Liu, W., et al. (2022) · Journal of Dental Research · doi:10.1177/00220345221092752 · Cited by 38
“Prior studies found the barrier dysfunction of the airway and intestinal epithelium in T2D (Yu et al. 2016; Thaiss et al. 2018), leading to increased permeability and infection (Break et al. 2021).”
BackgroundSpicy Food and Chili Peppers and Multiple Health Outcomes: Umbrella Review
Ao, Z., Huang, Z., & Liu, H. (2022) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202200167 · Cited by 36
Causality in dietary interventions—building a case for gut microbiota
Lam, Y. Y., Zhang, C., & Zhao, L. (2018) · Genome Medicine · doi:10.1186/s13073-018-0573-y · Cited by 35
Advances in the Interaction between Food-Derived Nanoparticles and the Intestinal Barrier
Jiang, B., Zhao, Y., Cao, Y., Sun, C., Lu, W. J., & Fang, Y. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c08145 · Cited by 36
Effect of High Glucose on Ocular Surface Epithelial Cell Barrier and Tight Junction Proteins
Alfuraih, S., Barbarino, A., Ross, C. A., Shamloo, K., Jhanji, V., Zhang, M., & Sharma, A. (2020) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.61.11.3 · Cited by 36
Sardu, C., Trotta, M. C., Santella, B., D’Onofrio, N., Barbieri, M., Rizzo, M. R., Sasso, F. C., Scisciola, L., Turriziani, F., Torella, M., et al. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108670 · Cited by 36
Wu, L., Lu, P., Guo, X., Song, K., Lyu, Y., Bothwell, J. D., Wu, J., Hawkins, O., Clarke, S. L., Lucas, E. A., et al. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.01.003 · Cited by 35
“Immunohistochemistry staining was performed as described, with some modifications [42].”
MethodGrabia, M., Markiewicz‐Żukowska, R., & Socha, K. (2021) · Nutrients · doi:10.3390/nu13061782 · Cited by 39
“By inducing intestinal hyperglycemia, the authors discovered that HbA1c was a marker positively connected with an increase in serum receptor pathogen recognition (PRR) ligands [76].”
BackgroundKeeping It Local in Metabolic Disease: Adipose Tissue Paracrine Signaling and Insulin Resistance
KAHN, D. E., & Bergman, B. C. (2022) · Diabetes · doi:10.2337/dbi21-0020 · Cited by 41
Sohail, M. U., Mashood, F., Oberbach, A., Chennakkandathil, S., & Schmidt, F. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1042362 · Cited by 38
“Individualized glycemic control, as measured by HbA1c, correlates with systemic transport of gut microbiome secretions (Thaiss et al., 2018).”
BackgroundEffect of anthocyanins on metabolic syndrome through interacting with gut microbiota
Du, L., Ding, X., Tian, Y., Chen, J., & Li, W. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107511 · Cited by 36
Xiao, Y., Li, K., Bian, J., Liu, H., Zhai, X., El-Omar, E. M., Han, L., Gong, L., & Wang, M. (2022) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202100863 · Cited by 36
Xu, K., Ren, Y., Zhao, S., Feng, J., Wu, Q., Gong, X., Chen, J., & Xie, P. (2024) · Communications Biology · doi:10.1038/s42003-023-05759-1 · Cited by 32
“Moreover, hyperglycemia would increase the permeability of the intestinal barrier, giving microbes a better chance to enter the body and causing the proliferation of pathogenic bacteria 16 .”
Woodward, S. E., Krekhno, Z., & Finlay, B. B. (2019) · Cellular Microbiology · doi:10.1111/cmi.13107 · Cited by 36
“Upon transport into cells via glucose transporter GLUT2, glucose was shown to directly alter tight junction integrity of Caco-2 intestinal epithelial cells, with evidence for the same effect in humans (Thaiss et al., 2018).”
BackgroundRowan, S., Jiang, S., Chang, M., Volkin, J., Cassalman, C., Smith, K., Streeter, M. D., Spiegel, D. A., Neto, C. A. M., Rabbani, N., et al. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.02.010 · Cited by 33
“Hyperglycemic mice have similar phenotypes (91).”
Manilla, V., Tommaso, N. D., Santopaolo, F., Gasbarrini, A., & Ponziani, F. R. (2023) · Microorganisms · doi:10.3390/microorganisms11020267 · Cited by 32
Metadata
- Authors
- Thaiss, C. A., Levy, M., Grosheva, I., Zheng, D., Soffer, E., Blacher, E., Braverman, S., Tengeler, A. C., Barak, O., Elazar, M., Ben-Zeev, R., Lehavi-Regev, D., Katz, M. N., Pevsner-Fischer, M., Gertler, A., Halpern, Z., Harmelin, A., Aamar, S., Serradas, P., Grosfeld, A., Shapiro, H., Geiger, B., & Elinav, E.
- Affiliations
- Weizmann Institute of Science (IL)
- Hebrew University of Jerusalem (IL)
- Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.
- Tel Aviv Sourasky Medical Center (IL)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Elinav, Eran
- ORCID
- Venue
- Science
- Published
- 2018-03-23
- Volume
- 359
- Issue
- 6382
- Pages
- 1376-1383
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2794419196
- Cited by
- 942
- References
- 56
- Citations by year
- 2026: 91 · 2025: 134 · 2024: 129 · 2023: 102 · 2022: 142 · 2021: 126 · 2020: 102 · 2019: 74 · 2018: 38
- FWCI
- 30.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Science (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- Bill & Melinda Gates Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Keywords
- hyperglycemia, intestinal barrier dysfunction, gastrointestinal infections, obesity, diabetes mellitus, GLUT2, intestinal epithelial cells, tight junctions, adherens junctions, intestinal permeability, microbial translocation, HbA1c, glycemic control, gut microbiota, systemic inflammation
- MeSH terms
- Gastrointestinal Microbiome, Animals, Blood Glucose, Diabetes Mellitus, Experimental, Escherichia coli Infections, Glucose, Humans, Hyperglycemia, Intestinal Diseases, Intestinal Mucosa, Mice, Inbred Strains, Obesity, Permeability, Streptozocin, Gene Deletion, Caco-2 Cells, Citrobacter rodentium, Glucose Transporter Type 2, Mice, Enteropathogenic Escherichia coli, Receptors, Leptin, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.